Russ Altman (Stanford University) & Kim Branson (GSK) - Principled Engineering: AI and Drug Development

Entrepreneurial Thought Leaders (ETL)

Stanford eCorner

Journey, Startups, Education, Stanford, Culture, Strategy, Stanford University, Entrepreneurship, Business, Life Lessons, Thought Leadership, Creativity, Etl, Challenges, Leadership, Innovation, Founders

4.4 • 739 Ratings

🗓️ 9 March 2022

⏱️ 58 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Russ Altman is the Kenneth Fong Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science and (by courtesy) Computer Science at Stanford University. His primary research interests are in the application of computing to problems relevant to medicine. Kim Branson is a senior vice president and Global Head of Artificial Intelligence and Machine Learning at GSK, where he leads the GSK.ai team, a group of nearly 100 machine learning researchers and engineers who are pioneering the application of AI to drug discovery and development. In this conversation with Stanford adjunct lecturer and STVP Director of Principled Entrepreneurship Jack Fuchs, Altman and Branson discuss how ethics and principles can shape innovation at the intersection of AI and drug development.

--------------------

Stanford eCorner content is produced by the Stanford Technology Ventures Program. At STVP, we empower aspiring entrepreneurs to become global citizens who create and scale responsible innovations.

CONNECT WITH US

Twitter: https://twitter.com/ECorner

LinkedIn: https://www.linkedin.com/company/stanfordtechnologyventuresprogram/

Facebook: https://www.facebook.com/StanfordTechnologyVenturesProgram/

YouTube: https://www.youtube.com/user/ecorner

LEARN MORE

eCorner Website: https://ecorner.stanford.edu/

STVP Website: https://stvp.stanford.edu/

Support our mission of providing students and educators around the world with free access to Stanford University's network of entrepreneurial thought leaders: https://ecorner.stanford.edu/give.

Transcript

Click on a timestamp to play from that location

0:00.0	Who you are defines how you build.
0:06.8	This is the Entrepreneurial Thought Leaders series.
0:10.7	Brought to you by Stanford E. Corner.
0:14.1	Welcome to Winter Quarter's final entrepreneurial thought leaders series live stream.
0:20.1	We've teamed up with the dean's office at
0:21.9	Stanford School of Engineering to create a special ETL session focused on Stanford's thought
0:27.1	leadership in how ethics and principles can shape innovation. Today is the first and what we plan to be a series of
0:34.2	events that will engage both School of Engineering alumni and Stanford students
0:39.9	in vital conversations about the role of ethics in engineering and innovation across disciplines.
0:47.8	I'm Jack Fuchs, adjunct lecturer at Stanford, and director of principled entrepreneurship at STVP.
1:02.0	If you're familiar with STVP, you know that we strive to equip every student with the tools to brave ethical complexity. We believe that if people and organizations have well-articulated principles, they will make better decisions.
1:10.0	In my own teaching, we take students on a journey
1:12.8	where they develop their own values and principles they will bring with them in their careers.
1:18.1	They will then help instill those principles in their organizations, helping better navigate
1:23.2	difficult decisions. For today's session, we're thrilled to welcome Dr. Russ Altman and Dr. Kim Branson for a conversation
1:31.7	about the ethical issues at play at the intersection of artificial intelligence and drug discovery.
1:40.0	Russ is the Kenneth Fong professor of bioengineering, genetics, medicine, biomedical data science, and computer science at Stanford, and is a past chair of Stanford's bioengineering department.
1:52.8	His primary research interests are in the application of computing to problems relevant to medicine.
1:59.2	He also holds a Sirius XM radio show and podcast entitled The Future of Everything.
2:05.8	We will put a link to this podcast in the chat.
2:09.6	Kim is a senior vice president and global head of artificial intelligence and machine learning at Glaxo Smith-Kline, GSK.
2:19.0	He leads the GSC.AI team, a global organization of nearly 100 machine learning researchers and
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Stanford eCorner, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Stanford eCorner and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.